Articles tagged with Cancer Treatments
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A new urine-based test has been developed to detect kidney cancer, showing promising results in early diagnosis. The test identified gene changes in the urine of patients with kidney cancer that matched those found in tumor samples, indicating its potential as a diagnostic tool.
A new animal model of pancreatic cancer has been developed, which mimics both non-invasive and invasive forms of the disease. The study identified a unique protein signature in the blood of animals with precancerous lesions, offering potential for early detection and therapeutic targets.
A higher dose of Gleevec was found to lead to increased remission in patients with chronic myeloid leukemia (CML), with 28% of patients achieving complete molecular response after 18 months. The treatment showed improved results over time, with a significant reduction in disease progression.
The American Society of Hematology presents the 2003 Public Service Award to Sen. Dianne Feinstein for her leadership on medical research and patient care issues. ASH also awards Dr. Claude Lenfant with its first-ever Lifetime Service Award for his decades-long dedication to hematology research and training.
AstraZeneca scientists have discovered selective and potent inhibitors of Aurora kinase activity that may have potential application in human cancer treatment. New pre-clinical research presents a combination of vascular targeting agents with EGFR tyrosine kinase inhibitors, showing greater anti-tumor activity than either agent alone.
A UCLA study has found that younger women with breast cancer often experience persistent energy loss and psychological difficulties, despite overall good quality of life. The study highlights the need for targeted interventions to support these subgroups.
The new guidelines call for searches within the National Marrow Donor Program registry conducted by histocompatibility specialists, with patients HLA typed to a high degree of resolution. High-resolution HLA typing is essential for all transplant patients, and the guidelines encourage considering transplants even without a perfect match.
Researchers at the Beckman Laser Institute are developing a laser-based technology to detect and analyze tumors, providing detailed information on blood, fat, and water composition. The center aims to transform this cutting-edge science into a versatile tool for cancer research.
A new study by Georgetown University Medical Center researchers found that low-dose CT screenings can accelerate smoking cessation rates by 14%, significantly higher than the national average. This promising finding suggests it's never too late to treat nicotine dependence, and further research may lead to more effective interventions.
A multi-center study led by Fox Chase Cancer Center oncologist aims to develop an interactive internet-based tool to assess patient values and information needs, providing education on cancer treatment and communication skills training. The goal is to improve doctor-patient communication and patient satisfaction.
A new study by St. Jude Children's Research Hospital found that black children with acute lymphoblastic leukemia (ALL) can achieve high cure rates comparable to those of white children, contradicting previous clinical studies. The research suggests that personalized risk-directed therapy played a key role in overcoming disparities in t...
Researchers used DNA microarray technology to identify seven major subtypes of pediatric acute lymphoblastic leukemia, including six known prognostic subtypes. This discovery enables more accurate diagnoses and personalized treatment plans based on a patient's unique expression profile.
Researchers at Duke University Medical Center have developed a strategy using erythropoietin to enhance heart function and prevent cell death after ischemic injury. A novel protective effect of erythropoietin has been shown in the infarcted heart, demonstrating a therapeutic window of opportunity for acute protection and long-term pres...
A study published by the University of Pittsburgh found that hormone therapy has no benefit to postmenopausal women, even those at high risk of fracture. The research suggests that estrogen plus progestin increases bone mineral density but does not outweigh risks associated with breast cancer and heart disease.
A large-scale study from Massachusetts General Hospital finds radiofrequency ablation (RFA) to be the most effective treatment for osteoid osteoma, a type of benign bone tumor. RFA offers a high success rate and low complication rate, making it an attractive alternative to traditional surgery and medication.
The EU's new clinical trial directive may hinder international collaborations, leading to delays in cancer treatment development. This could result in patients being deprived of life-saving treatments, as the effectiveness of new drugs would be determined solely by pharmaceutical industry-sponsored research.
A new clinical trial led by Duke University aims to compare the efficacy of two pegylated interferon treatments for hepatitis C virus. The IDEAL trial will enroll 2,880 patients and determine which treatment results in a sustained viral response in the largest proportion of patients.
The study found that initiating Avonex treatment immediately after MS symptoms appeared reduced the development of clinically definite MS by 35% and relapses by 48% compared to delayed initiation. Early intervention also led to higher likelihood of being classified as clinically stable between years four and five.
The STEPS study evaluates the safety and efficacy of Spheramine, a cell therapy that produces levodopa to enhance dopamine production in the brain. The study aims to provide a new method for Parkinson's patients to achieve continuous control of motor function.
Researchers developed a powerful new method called ROMA to compare normal cell DNA with breast cancer DNA, revealing chromosomal amplifications and deletions involved in breast cancer. The study also found large copy number polymorphisms in healthy cells that may underlie human traits.
Researchers at the University of Houston are studying DNA transcription errors called bulges, which can lead to cancer. The team hopes to understand how these mistakes are recognized and repaired by the body's 'spellcheckers' to develop more effective cancer treatments.
Scientists have discovered that cells can adapt to survive without oxygen, a key finding that could lead to new treatments for cancer, heart attack, and stroke. Researchers are tracing the signaling pathways for cell injury and death, with hopes of identifying therapeutic tools to switch cellular behavior.
The University of Georgia has received a $6.7M grant to develop technologies for mapping the glycome of stem cell lines established by Bresagen. This research will lead to the isolation of specific nerve cells for Parkinson's treatment and new ways to diagnose and treat cancer.
The AACR-Gertrude B. Elion Cancer Research Award supports meritorious basic, translational, or clinical cancer research by a tenure-track scientist at an academic institution worldwide. Five Career Development Awards will be granted in 2004 to support research in various areas of cancer research.
Researchers found that hypnosis did not provide better pain relief compared to non-hypnotic treatments. The amount of pain relief experienced was largely due to participants' expectations from the therapy, according to the study's lead author.
A substantial increase in breast cancer risk is associated with combination hormone replacement therapy, particularly oestrogen-progestogen therapy. Current users of HRT have a 22% increased risk of death from breast cancer compared to never-users.
The American Association for Cancer Research (AACR) is seeking nominations for its Professorship in Basic Cancer Research, which provides a $50,000 grant for research expenses. The AACR-NFCR Professorship was established to honor Franklin and Tamara Salisbury and support cutting-edge basic cancer research.
Researchers found that meclofenamic acid and flurbiprofen, a currently clinical-trialled drug for prostate and colon cancer, effectively decreased Abeta42 levels by targeting gamma-secretase. This provides promising avenues for Alzheimer's treatment and furthers understanding of how NSAIDs impact AD.
Early detection and treatment of allergies can prevent serious complications and modify the progression of pediatric allergies. A specific IgE blood test can accurately diagnose atopy and guide treatment, including avoidance therapy and medication.
Dr. Collier's pioneering research has led to significant advances in vaccine design and therapeutic development, with applications in anthrax treatment and cancer therapy.
Researchers identified 58 genes dissimilar between normal and left-sided tumor samples, and 118 between normal and right-sided tumor samples. The study provides new insights into why some patients respond to treatment while others do not.
The Lombardi Cancer Center will investigate how drinking affects breast cancer risk, focusing on estrogens, free radicals, and gene mutations. The center aims to improve public health recommendations and inform individual lifestyle choices.
Researchers found that MYC binds to the WRN gene promoter, activating WRN expression and promoting cellular senescence in tumor cells. This discovery suggests a potential therapeutic target for cancer treatment by inhibiting WRN in MYC-induced tumor cells.
FDG PET demonstrates high accuracy for diagnosing infection and inflammation, with a sensitivity of 93% and specificity of 84%, according to a study analyzing 844 scans on 806 patients.
A combination of bevacizumab and erlotinib has shown a 21 percent response rate in patients with recurrent stage IIIb or IV lung cancer, with five patients experiencing partial responses and tumor stabilization for over a year. The treatment was well-tolerated with mild to moderate toxicity.
Research reveals that survivors of childhood cancer are experiencing significant sleep disturbances even years after completing treatment. The University of Minnesota study aims to investigate the causes and effects of these issues.
The AACR is now accepting nominations for its Cancer Prevention Research Award. Candidates must have made significant contributions to the field and be able to present a lecture at an upcoming conference in Phoenix, Arizona. The winner will receive $5,000 and support to attend the meeting.
A study found that MR imaging identified 86% of residual disease, outperforming mammography in detecting disease near the lumpectomy site. The imaging modality was also most accurate in identifying disease in different quadrants than the original tumor site.
A modified adenovirus, Delta-24-RGD, has shown improved infectivity and replication efficiency compared to the unmodified Delta-24. This leads to increased cytopathic effects and prolonged survival rates in mouse models of human glioma. The authors conclude that Delta-24-RGD may be an effective agent in treating gliomas.
Researchers at Johns Hopkins Medicine discovered a BRAF gene mutation in 68% of papillary thyroid cancers, which can be challenging to distinguish from benign conditions. This mutation causes continuous cell growth and division, leading to cancer.
A study of 1,383 cancer patients found that uninsured patients paid more for healthcare services but received significantly fewer treatments and services compared to insured patients. The disparity was attributed to various factors, including age at diagnosis and insurance coverage by race and ethnicity.
Researchers identified lifestyle factors that predict prostate cancer recurrence in treated patients. Patients with low body mass index, regular exercise, and annual screenings had lower risk of progression.
The American Academy of Neurology identifies five categories of reasons for treatment failure in headache patients. Incomplete or incorrect diagnoses are the most common reason, followed by unaddressed factors that exacerbate the headache. The experts also highlight inadequate medication regimens and lack of non-drug treatment options ...
Researchers are investigating new methods to combat cancer growth through computer models and cytotoxic treatments. They also discovered that a process called Auger emission can cause electrons to be emitted in well-defined directions by single molecules, leading to potential breakthroughs in physics research.
Researchers at Fox Chase Cancer Center developed a transgenic mouse model of epithelial ovarian cancer, allowing scientists to study the disease's progression from early stages. The model has the potential to facilitate advances in early detection and treatment of ovarian cancer.
The University of Pittsburgh will conduct a new study on acupuncture's effectiveness in alleviating hot flashes, insomnia, and nervousness in breast cancer survivors experiencing menopause. The study aims to explore the potential benefits of acupuncture for reducing cortisol levels and promoting relaxation.
A single-visit approach combining visual inspection with acetic acid wash (VIA) followed by cryotherapy shows promising results in rural Thailand, with 94% of women testing negative for VIA at one year's follow-up. The program is safe, acceptable, and feasible, achieving moderate population coverage with high satisfaction rates.
A study published in The Lancet found that same-day testing and treatment led to high rates of compliance with recommended treatment, with 83.2% returning for a follow-up visit. The 'one-stop' approach also improved patient satisfaction, with nearly 98% saying the treatment was equal to or better than expected.
A Mayo Clinic phase II study of 42 patients with advanced androgen-independent prostate cancer found that green tea did not provide therapeutic benefit. The study showed no sustained decline in PSA levels, and high doses of green tea were associated with significant side effects.
Tamoxifen treatment reduced the risk of benign breast disease and biopsies in high-risk women. Women treated with tamoxifen had a 28% lower incidence of benign diseases than those on placebo.
A study by Duke University researchers found that outpatient Mohs micrographic surgery is safe, with a complication rate of 1.64% out of 1,343 procedures performed in 2000. The results counter concerns raised by lobbyists and policymakers about the safety of outpatient surgeries.
Researchers have discovered a novel photoreceptor system in the human eye that controls melatonin production, which plays a key role in circadian rhythms. The study suggests that exposure to blue light at night may disrupt melatonin production and increase the risk of breast cancer.
A recent study found that combination hormone therapy increased the risk of stroke in postmenopausal women, including those with and without high blood pressure. The therapy was found to be ineffective for primary prevention of cardiovascular disease and heart attack.
The discovery of neurofibromin regulation may help develop targeted therapies to block neurofibromin degradation in NF1 patients and treat cancers with amplified Ras activity. Nf1 heterozygous cells show increased sensitivity to growth factors, suggesting even diminished neurofibromin levels can affect normal cell behavior.
Researchers found that selenium supplements reduced DNA damage in elderly male dogs' prostates, potentially benefiting aging prostate health. A separate study suggests a new retinoid treatment may prevent lung cancer in former smokers by restoring RAR-ß expression and reducing squamous metaplasia.
A study by Ohio State University found that topical oxygen therapy significantly improved healing rates for difficult-to-treat wounds, including diabetic hand ulcers and bedsores. The therapy, which involves applying pure oxygen to the wound, showed a 75% healing rate for acute traumatic injuries.
Researchers found that nicotine stimulates lung epithelial cells to activate a molecular pathway promoting cell growth and survival. This activation undermines the body's natural defense mechanism against cancer. The study suggests reconsidering the risk-benefit ratio of nicotine-based quitting aids.
Research reveals nicotine activates Akt survival pathway, undermining programmed cell death in lung cancer cells. This finding may lead to re-evaluation of quitting-aids' benefits.
A recent study published in the Journal of the National Cancer Institute found that combination hormone therapy was associated with a 3-5% increase in breast density, while estrogen alone had no effect. This suggests that increased breast density may be a valid marker for the effect of interventions on breast cancer risk.
A survey of 1,120 cancer physicians reveals substantial differences in views about the purpose of clinical trials. Pediatric oncologists are more likely to enroll patients in trials for state-of-the-art treatment, while other specialties prioritize scientific advancement and future patient care.